NEW YORK ( TheStreet) -- If you're a current Mako Surgical (MAKO) investor, Monday night's sales release must have felt like an operation filled with complications and every side effect has your name on it.Florida-based medical device maker Mako Surgical announced that Mako sold nine RIO systems in the second-quarter, well below Wall Street's expectation. The sales figure for the first half of 2012, is a disappointing 15 units.
Mako: Blood Is Flowing in the Street
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.